FindTrial
Sign In

Thoracoscopic adjunct minimally invasive mitral valve lesions with atrial fibrillation

Thoracoscopic adjunct minimally invasive mitral valve lesions with atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067539
Enrollment
Unknown
Registered
2023-01-11
Start date
2023-01-11
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Minimally invasive group:Thoracoscopic adjunct minimally invasive mitral valve lesions with atrial fibrillation
Thoracotomy group:The traditional method of thoracotomy is mitral valve replacement or 16 repair and RF ablation of atrial fibrillation

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: (1) Patients with medium-severe lesions (stenosis/regurgitation) of the mitral valve and patients with atrial fibrillation; (2) complex persistent atrial fibrillation; (3) Patients who have previously undergone catheter ablation and relapse; (4) Patients with high risk factors for fracture nonunion, such as osteoporosis, advanced age, diabetes, etc.

Exclusion criteria

Exclusion criteria: Patients with previous cardiac or pulmonary surgery; Extensive intrathoracic adhesions; Those with poor respiratory function and difficulty tolerating anesthesia, etc

Design outcomes

Primary

MeasureTime frame
24-hour Holter monitor;Atrial fibrillation conversion rate;Cardiac function index;—

Secondary

MeasureTime frame
Days in hospital;visual analog scale;—

Countries

China

Contacts

Public ContactYongjun Qian

Department of cardiovascular surgery, West China Hospital, Sichuan University

qianyongjun@scu.edu.cn13458512199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026